Envista Holdings Corporation

Envista Holdings Corporation develops, manufactures, markets, and sells dental products globally. The company operates in two segments: Specialty Products & Technologies, and Equipment & Consumables. The Specialty Products & Technologies segment offers dental implant systems, guided surgery systems, biomaterials, prosthetics, orthodontic brackets and wires, clear aligners, and digital orthodontic treatments under brands like Nobel Biocare, Ormco, Spark, and Damon. The Equipment & Consumables segment provides digital imaging systems, software, endodontic systems, restorative materials, and infection prevention products under brands such as Dexis, Kerr, Metrex, and CaviWipes. Envista serves oral surgeons, prosthodontists, periodontists, general dentists, and orthodontic laboratories.

Envista Holdings Corporation is listed on the New York Stock Exchange (NYSE) under the ticker symbol NVST. Its shares are traded in US Dollars (USD), as the company is headquartered in the United States. The exchange and currency reflect its primary listing in the US equity market, making it accessible to investors through US-based brokerage accounts.

Envista Holdings Corporation operates in the Healthcare sector, specifically within the Medical Instruments & Supplies industry. This classification reflects its focus on manufacturing and supplying dental products, including instruments, equipment, and consumables used by dental professionals. The company's products range from implant systems and orthodontic solutions to digital imaging and infection prevention supplies, all serving the dental healthcare market.

Envista Holdings Corporation is headquartered in Brea, California, United States. The company serves global markets, with its products used by dental professionals worldwide, including oral surgeons, prosthodontists, periodontists, general dentists, and orthodontic laboratories. While its primary operations are based in the US, its brand portfolio—such as Nobel Biocare, Ormco, and Kerr—has a strong international presence, catering to dental clinics, offices, and hospitals across various regions.

Envista Holdings generates revenue through two main segments: Specialty Products & Technologies and Equipment & Consumables. The Specialty Products & Technologies segment sells dental implant systems, guided surgery systems, biomaterials, prosthetics, orthodontic brackets, clear aligners, and digital orthodontic treatments under brands like Nobel Biocare, Ormco, and Spark. The Equipment & Consumables segment offers digital imaging systems, software, endodontic systems, restorative materials, bonding agents, and infection prevention products under brands such as Dexis, Kerr, and Metrex. Revenue comes from sales to dental offices, clinics, and hospitals globally.